| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0074-1055-01 | 0074-1055 | HUMAN PRESCRIPTION DRUG | EMRELIS | Telisotuzumab Vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20250514 | N/A | BLA | BLA761384 | AbbVie Inc. | TELISOTUZUMAB VEDOTIN | 100 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
| 0074-1044-01 | 0074-1044 | HUMAN PRESCRIPTION DRUG | EMRELIS | Telisotuzumab Vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20250514 | N/A | BLA | BLA761384 | AbbVie Inc. | TELISOTUZUMAB VEDOTIN | 20 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE |